XML 73 R63.htm IDEA: XBRL DOCUMENT v3.21.2
Business Combinations - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2021
Apr. 30, 2017
Sep. 30, 2021
Sep. 30, 2021
May 31, 2021
Business Acquisition [Line Items]          
Goodwill     $ 48,749,000 $ 48,749,000  
Customer Relationships          
Business Acquisition [Line Items]          
Estimated amortization life of identified intangible assets assumed       12 years  
Laboratory Information System Platform          
Business Acquisition [Line Items]          
Estimated amortization life of identified intangible assets assumed       5 years  
Trade Name          
Business Acquisition [Line Items]          
Estimated amortization life of identified intangible assets assumed       10 years  
FF Gene Biotech          
Business Acquisition [Line Items]          
Minority interest ownership percentage   28.00%      
FF Gene Biotech          
Business Acquisition [Line Items]          
Business Combination,Fair value of noncontrolling interest   $ 8,141,000      
Percentage of effective investment   42.00%      
Purchase price for effective investment   $ 19,000,000.0      
Percentage of preexisting equity interest     30.00% 30.00%  
Gain recognized on preexisting investment     $ 3,700,000 $ 3,700,000  
Goodwill   23,082,000 23,100,000 23,100,000  
Identified intangible assets assumed   6,958,000      
FF Gene Biotech | Royalty-Free Technology          
Business Acquisition [Line Items]          
Identified intangible assets assumed   $ 5,700,000      
Estimated amortization life of identified intangible assets assumed   10 years      
FF Gene Biotech | Customer Relationships          
Business Acquisition [Line Items]          
Identified intangible assets assumed   $ 1,200,000      
Estimated amortization life of identified intangible assets assumed   5 years      
Cytometry Specialists, Inc          
Business Acquisition [Line Items]          
Goodwill $ 25,732,000   25,700,000 25,700,000  
Identified intangible assets assumed $ 30,540,000        
Percentage of acquisition of outstanding equity 100.00%        
Undiscounted amounts required to pay under contingent consideration agreement, minimum $ 0        
Undiscounted amounts required to pay under contingent consideration agreement, maximum 10,000,000.0        
Fair value of the contingent consideration recognized 8,500,000        
Cytometry Specialists, Inc | Customer Relationships          
Business Acquisition [Line Items]          
Identified intangible assets assumed $ 27,600,000        
Estimated amortization life of identified intangible assets assumed 12 years        
Cytometry Specialists, Inc | Laboratory Information System Platform          
Business Acquisition [Line Items]          
Identified intangible assets assumed $ 1,900,000        
Estimated amortization life of identified intangible assets assumed 5 years        
Cytometry Specialists, Inc | Trade Name          
Business Acquisition [Line Items]          
Identified intangible assets assumed $ 1,100,000        
Estimated amortization life of identified intangible assets assumed 10 years        
Discount for Lack of Marketability | FF Gene Biotech          
Business Acquisition [Line Items]          
Business combination, contingent consideration, liability, measurement input   28      
Discount | FF Gene Biotech          
Business Acquisition [Line Items]          
Business combination, contingent consideration, liability, measurement input   35      
Discount Owed to Market Participant Acquisition Premium | FF Gene Biotech          
Business Acquisition [Line Items]          
Business combination, contingent consideration, liability, measurement input   10      
Xilong Scientific          
Business Acquisition [Line Items]          
Equity interest to be made in joint venture         72.00%
FF Gene Biotech          
Business Acquisition [Line Items]          
Equity interest to be made in joint venture   30.00%      
General and Administrative          
Business Acquisition [Line Items]          
Acquisition related costs     $ 2,200,000 $ 2,800,000